Recording Date: September 19th
Presenter: Joe Spinelli, CCO of MedTek21

Summary of Webinar

Evidence-based pharmacogenomic prescribing guidance can be used to improve care and reduce costs for entire patient populations, yet therapeutic decisions around prescribed medications are ultimately in the hands of clinical prescribers. Decision support at the point of care empowers clinicians with intelligent, real-time tools that assist their independent review and remediation of medication regimens on a personalized basis.

Join Translational Software partner MedTek21 as they discuss how the TSI API enables their clinical customers to seamlessly assess, measure, and report on valuable drug-to-gene reporting information as part of their overall medication assessment procedures.


About the Presenter

Joe-SpinelliJoe Spinelli is CCO of MedTek21, where he oversees program design, utilization, and data analysis for personalized medication risk management programs currently in use by national clinical and consulting pharmacy organizations. Prior to joining the founding team of MedTek21, Mr. Spinelli spent over fifteen years as both an operator and investor in the healthcare IT, finance, and consumer sectors. Mr. Spinelli has a BS, summa cum laude, from Babson College and was the recipient of the Earl K. Bowen Award for excellence in quantitative methods.